SS
YARW

Steve Schonfeld’s Yarrow Bioscience YARW Stock Holding History

Steve Schonfeld’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,239
Closed -$267K – 2618
2025
Q2 		$267K Buy
3,239
+1,539
+91% +$100K ﹤0.01% 1722
2025
Q1 		$134K Sell
1,700
-1,833
-52% -$226K ﹤0.01% 1990
2024
Q4 		$592K Buy
3,533
+161
+5% +$21.1K ﹤0.01% 1326
2024
Q3 		$317K Sell
3,372
-952
-22% -$90.2K ﹤0.01% 1630
2024
Q2 		$426K Sell
4,324
-72
-2% -$8.98K ﹤0.01% 1558
2024
Q1 		$675K Buy
+4,396
New +$474K ﹤0.01% 1363
2021
Q2 		– Sell
-19
Closed -$119K – 2348
2021
Q1 		$119K Sell
19
-2
-10% -$14.5K ﹤0.01% 1610
2020
Q4 		$119K Sell
21
-41
-66% -$258K ﹤0.01% 1425
2020
Q3 		$368K Sell
62
-43
-41% -$251K 0.01% 1015
2020
Q2 		$657K Buy
+105
New +$711K 0.02% 721
2018
Q4 		– Sell
-14
Closed -$493K – 1247
2018
Q3 		$493K Hold
14
– – 0.02% 580
2018
Q2 		$406K Buy
+14
New +$544K 0.02% 575

Other funds holding YARW

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Steve Schonfeld's YARW Position: Q3 2025 in Review

Steve Schonfeld sold out of Yarrow Bioscience (YARW) in Q3 2025, closing a stake of 3,239 shares — an estimated $267K sold.

Steve Schonfeld first reported a position in YARW in Q2 2018 and held it in 12 quarters. The position peaked at $675K in Q1 2024. 34 funds tracked by Wall St. Rank hold YARW as of Q3 2025.

  • Steve Schonfeld reported no remaining Yarrow Bioscience position as of Q3 2025 after selling out during the quarter.
  • Steve Schonfeld sold 3,239 Yarrow Bioscience shares in Q3 2025, an estimated $267K.
  • Steve Schonfeld first reported a position in Yarrow Bioscience in Q2 2018 and held it in 12 quarters.
  • Steve Schonfeld's Yarrow Bioscience position peaked at $675K in Q1 2024.
  • 34 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.